Skip to main content

Table 3 Risk factor distribution in high-risk category, using model-specific thresholds

From: Comparing six cardiovascular risk prediction models in Haiti: implications for identifying high-risk individuals for primary prevention

 

PCE

adjusted PCE

Framingham- Lipids

Framingham- BMI

WHO-Lipids

WHO-BMI

Percent of cohort categorized as high-risk by risk calculator

41.4%

27.4%

18.0%

22.0%

2.5%

1.8%

n

557

368

731

818

390

39

Female, n (%)

295 (53.0)

162 (44.0)

375 (51.3)

420 (51.3)

208 (53.3)

208 (53.3)

Age, median [25th to 75th percentile], y

62 [57, 68]

63 [57, 69]

60 [54, 66]

59 [53, 65]

66 [61, 70]

66 [61, 70]

Diabetes Mellitus, n (%)

80 (14.4)

68 (18.5)

94 (12.9)

96 (11.7)

35 (9.0)

35 (9.0)

Current smoker, n (%)

39 (7.0)

31 (8.4)

45 (6.2)

46 (5.6)

30 (7.7)

30 (7.7)

SBP treated, median [25th to 75th percentile], mmHg

155

[144, 172]

157

[146, 176]

152

[141, 169]

151

[138, 168]

161

[150, 179]

161

[150, 179]

SBP not treated, median [25th to 75th percentile], mmHg

146

[133, 162]

159

[144, 173]

143

[130, 158]

142

[129, 157]

148

[136, 166]

148

[136, 166]

Total Cholesterol, median [25th to 75th percentile], mg/dL

198

[170, 223]

198

[171, 224]

199

[171, 224]

192

[164, 218]

197

[168, 221]

197

[168, 221]

HDL Cholesterol, median [25th to 75th percentile], mg/dL

47 [40, 55]

47 [40, 55]

47 [40, 55]

48 [41, 56]

50 [43, 59]

50 [43, 59]

  1. Legend: Model specific thresholds of high 10-year CVD risk were used to identify high-risk participants: PCE ≥ 7.5%; adjusted PCE ≥ 7.5%; Framingham-Lipids ≥ 20%; Framingham-BMI ≥ 20%; WHO-Lipids ≥ 20%; WHO-BMI ≥ 20%.